AzTrials
AzTrials

COVID-19 PneumoniaNCT04915001

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

An observational study of COVID-19 Pneumonia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The epidemic caused by the new coronavirus appeared in December 2019 and spread rapidly, and it has had a serious impact on the social development and people's lives in the world. On February 11, 2020, the World Health Organization (WHO) named the infectious disease caused by the virus COVID-19. Read more about this study

Who is it for?
Any age
Conditions the study is for
COVID-19 Pneumonia
How many people
181 participants
Where
1 siteChina
Study dates
9 Mar 2020to 30 Mar 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Not applicable, not included in patients

Who may be able to join

  • County-level people's hospitals, TCM hospitals and above comprehensive public hospitals in Zhejiang Province;
  • Voluntary participation in this study.

Who cannot join

  • Incomplete data

Trial locations and contacts

1 site in 1 country.

China1 site

  • Second Affiliated Hospital, Zhejiang University School of Medicine & Institute of Emergency Medicine, Zhejiang University

    Hangzhou, Zhejiang, 310009

Other trials in China

About this study

The epidemic caused by the new coronavirus appeared in December 2019 and spread rapidly, and it has had a serious impact on the social development and people's lives in the world. On February 11, 2020, the World Health Organization (WHO) named the infectious disease caused by the virus COVID-19. my country classifies it as a Class B infectious disease, and controls it as a Class A infectious disease. In order to effectively respond to the epidemic, on January 23, 2020, Zhejiang Province first launched a first-level response to major public health emergencies across the country. Some patients with new coronary pneumonia, especially critically ill patients, may go to the emergency department first. Emergency medical staff must identify and isolate patients with new coronary pneumonia in a timely manner while ensuring the treatment of critically ill patients. People face greater unknowns and challenges in the anti-epidemic work. this research Participating in the prevention and control of the new crown pneumonia epidemic through investigations in the emergency department of Zhejiang Province Related conditions, to further improve the hospital's emergency medical service capabilities for reference.

Read the detailed description

References：

  1. Huang CL, Wang YM, Li XW, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. DOI:10.1016/s0140-6736(20)30183-5.
  2. Zhu N, Zhang DY, Wang WL, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727- 733. DOI:10.1056/nejmoa2001017.
  3. Gupta M, Abdelmaksoud A, Jafferany M, et al. COVID-19 and economy[J]. Dermatol Ther, 2020: e13329. DOI:10.1111/dth.13329.
  4. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 [J]. Nat Microbiol, 2020, 5(4):536-544. DOI:10.1038/s41564- 020-0695-z.
  5. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges[J]. Int J Antimicrob Agents, 2020, 55(3): 105924. DOI:10.1016/j.ijantimicag.2020.105924.
Keywords
Emergency department, COVID-19, Epidemic prevention and control, Zhejiang province
Medical subject headings
Emergencies, COVID-19

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Basic information of the hospital

    Hospital level, whether it is a designated hospital for COVID-19, whether it is capable of detecting nucleic acid for the new coronavirus, whether it has a fever clinic

    Measured: 7 day

  2. Participation of the emergency department in fever clinics

    The department/department responsible for the management of the fever clinic, whether the medical staff of the fever clinic has a fixed establishment, and the medical staff that temporarily supports the fever clinic source department

    Measured: 7 day

  3. Patients with COVID-19 admitted to the emergency department

    Number and distribution of patients

    Measured: 7 day

  4. The frontline situation of emergency medical care support in the fight against the epidemic

    Support the fever clinic of this hospital, isolation observation ward/confirmed ward, participate in the prehospital/inter-hospital transfer of new crown cases, participate in the hospital/regional prevention and management expert group, support the ward/ICU of designated hospitals in the province, support the ward of Hubei Province /ICU/ Fangcang shelter hospital

    Measured: 7 day

  5. Epidemic prevention facilities in the emergency department

    Number of spare separate consultation rooms, ordinary rescue rooms, and negative pressure rescue rooms, the supply of early anti-epidemic protective equipment

    Measured: 7 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2021
  2. Study start9 Mar 2020
  3. Primary completion15 Mar 2020
  4. Study completion30 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
181 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04915001
Sponsor's protocol ID
2020-292
Status last verified
Mar 2020
First submitted
29 May 2021
Last updated
22 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of COVID-19 Pneumonia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Basic information of the hospital (time frame: 7 day). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04915001.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2021.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in